FDA Approves Belimumab for Children With Lupus Nephritis

Children with lupus-related kidney damage can now receive the B-cell reducing therapy that adults with lupus nephritis have been receiving for the past 2 years.

Related Keywords

United States ,Americans ,America ,Stevanw Gibson ,Kennethm Farber , ,Glaxosmithkline ,Lupus Research Alliance ,Drug Administration ,Lupus Foundation Of America ,Lupus Foundation ,Medscape Medical ,Lupus Research Alliance President ,